{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-062982","form_type":"8-K","ticker":"SRTS","cik":"0001494891","company_name":"Sensus Healthcare, Inc.","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.084361+00:00","generated_at":"2026-06-12T07:55:47.022500+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sensus Healthcare Q2 revenue $4.5M (-63% YoY), net loss $0.4M vs $3.5M profit last year","bullets":["Revenue $4.5M, down 63% YoY from $12.1M; net loss $0.4M ($0.02/sh) vs net income $3.5M ($0.21/sh) in Q2 2022.","Shipped 13 SRT systems (down from 33 YoY) but up from 10 in Q1; total installed base 708 systems worldwide.","Cash $20.1M, no debt; gross margin 57.9% vs 68.3% a year ago on lower volume and higher vendor costs.","Guidance: expects to ship at least 60 SRT systems in 2023 and return to profitability in H2 2023.","New UK/Ireland distribution with MIS Healthcare; first sale in Ireland; international expansion progressing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-062982","json":"https://secwatch.observer/filing/0001213900-23-062982.json","markdown":"https://secwatch.observer/filing/0001213900-23-062982.md","text":"https://secwatch.observer/filing/0001213900-23-062982.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023062982/0001213900-23-062982-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023062982/ea182698-8k_sensus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T07:55:47.022500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d7e59a1e91c616fd25973938acb67e8888d8d094","claim":"Sensus Healthcare, Inc. reported the three and six months ended June 30, 2023 results: revenue $4.5 million, net income $0.4 million, or $0.02 per share (net loss), EPS $0.02 per share. Guidance reaffirmed.","evidence_excerpt":"financial results for the three and six months ended June 30, 2023. Highlights from the second quarter of 2023 and recent weeks include the following: ● Achieved revenues of $4.5 million, an increase of 33% from $3.4 million for the first quarter of 2023 and a decrease from $12.1 million in the prior-year quarter reflecting lower SRT unit sales ● Shipped 13 SRT","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1494891/000121390023062982/0001213900-23-062982-index.htm","confidence":0.92,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and six months ended June 30, 2023"},{"label":"Revenue","value":"$4.5 million"},{"label":"Net income","value":"$0.4 million, or $0.02 per share (net loss)"},{"label":"EPS","value":"$0.02 per share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}